Gilead Sciences (GILD) Long-Term Deferred Tax (2009 - 2026)

Gilead Sciences has reported Long-Term Deferred Tax for 12 years, with the latest figure at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax fell 31.3% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (down 31.3% YoY), and the FY2025 full-year result was $2.0 billion, down 17.41% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $1.8 billion, down from $2.0 billion in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $2.7 billion in Q2 2025, with the low at $1.8 billion in Q1 2026.
• Historically, Long-Term Deferred Tax has averaged $2.2 billion across 3 years, with a median of $2.2 billion in 2024.
• Annual changes were most pronounced in 2025 — Long-Term Deferred Tax fell 17.41% — and 2026, when it plunged 31.3%.
• Gilead Sciences' Long-Term Deferred Tax stood at $2.4 billion in 2024, then decreased by 17.41% to $2.0 billion in 2025, then fell by 10.03% to $1.8 billion in 2026.
• The last three Long-Term Deferred Tax figures came in at $1.8 billion (Q1 2026), $2.0 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.